{"id":341230,"date":"2025-08-20T14:18:06","date_gmt":"2025-08-20T14:18:06","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-bridgebio-pharma\/"},"modified":"2025-08-20T14:18:06","modified_gmt":"2025-08-20T14:18:06","slug":"how-to-buy-bridgebio-pharma","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334117,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-341230","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu BridgeBio Pharma, Inc. (BBIO) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu BridgeBio Pharma, Inc. (BBIO)","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu BridgeBio Pharma, Inc. (BBIO) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu BridgeBio Pharma, Inc. (BBIO)"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO) v\u00e0 \u0111\u1ea7u t\u01b0 v\u00e0o c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ed5i m\u1edbi n\u00e0y. H\u01b0\u1edbng d\u1eabn \u0111\u1ea7y \u0111\u1ee7 v\u1edbi ph\u00e2n t\u00edch gi\u00e1, r\u1ee7i ro v\u00e0 d\u1ef1 b\u00e1o 2025-2030.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO) v\u00e0 \u0111\u1ea7u t\u01b0 v\u00e0o c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ed5i m\u1edbi n\u00e0y. H\u01b0\u1edbng d\u1eabn \u0111\u1ea7y \u0111\u1ee7 v\u1edbi ph\u00e2n t\u00edch gi\u00e1, r\u1ee7i ro v\u00e0 d\u1ef1 b\u00e1o 2025-2030."},"intro":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o m\u1ed9t c\u00f4ng ty th\u1ef1c s\u1ef1 thay \u0111\u1ed5i cu\u1ed9c s\u1ed1ng th\u00f4ng qua y h\u1ecdc di truy\u1ec1n? BridgeBio Pharma \u0111\u1ea1i di\u1ec7n cho m\u1ed9t trong nh\u1eefng c\u01a1 h\u1ed9i h\u1ea5p d\u1eabn nh\u1ea5t trong l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc hi\u1ec7n nay. V\u1edbi c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb \u0111\u1ed9t ph\u00e1 cho c\u00e1c b\u1ec7nh di truy\u1ec1n hi\u1ebfm g\u1eb7p v\u00e0 danh m\u1ee5c s\u1ea3n ph\u1ea9m th\u01b0\u01a1ng m\u1ea1i m\u1edbi b\u1eaft \u0111\u1ea7u c\u00f3 s\u1ee9c h\u00fat, c\u1ed5 phi\u1ebfu n\u00e0y c\u00f3 th\u1ec3 l\u00e0 v\u00e9 c\u1ee7a b\u1ea1n \u0111\u1ebfn c\u1ea3 t\u0103ng tr\u01b0\u1edfng t\u00e0i ch\u00ednh v\u00e0 t\u1ea1o ra s\u1ef1 kh\u00e1c bi\u1ec7t th\u1ef1c s\u1ef1 trong ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe. H\u00e3y c\u00f9ng ph\u00e2n t\u00edch t\u1ea5t c\u1ea3 nh\u1eefng g\u00ec b\u1ea1n c\u1ea7n bi\u1ebft \u0111\u1ec3 tham gia v\u00e0o BBIO.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o m\u1ed9t c\u00f4ng ty th\u1ef1c s\u1ef1 thay \u0111\u1ed5i cu\u1ed9c s\u1ed1ng th\u00f4ng qua y h\u1ecdc di truy\u1ec1n? BridgeBio Pharma \u0111\u1ea1i di\u1ec7n cho m\u1ed9t trong nh\u1eefng c\u01a1 h\u1ed9i h\u1ea5p d\u1eabn nh\u1ea5t trong l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc hi\u1ec7n nay. V\u1edbi c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb \u0111\u1ed9t ph\u00e1 cho c\u00e1c b\u1ec7nh di truy\u1ec1n hi\u1ebfm g\u1eb7p v\u00e0 danh m\u1ee5c s\u1ea3n ph\u1ea9m th\u01b0\u01a1ng m\u1ea1i m\u1edbi b\u1eaft \u0111\u1ea7u c\u00f3 s\u1ee9c h\u00fat, c\u1ed5 phi\u1ebfu n\u00e0y c\u00f3 th\u1ec3 l\u00e0 v\u00e9 c\u1ee7a b\u1ea1n \u0111\u1ebfn c\u1ea3 t\u0103ng tr\u01b0\u1edfng t\u00e0i ch\u00ednh v\u00e0 t\u1ea1o ra s\u1ef1 kh\u00e1c bi\u1ec7t th\u1ef1c s\u1ef1 trong ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe. H\u00e3y c\u00f9ng ph\u00e2n t\u00edch t\u1ea5t c\u1ea3 nh\u1eefng g\u00ec b\u1ea1n c\u1ea7n bi\u1ebft \u0111\u1ec3 tham gia v\u00e0o BBIO."},"body_html":"<h2>\ud83d\udcc8 V\u1ecb Tr\u00ed Th\u1ecb Tr\u01b0\u1eddng Hi\u1ec7n T\u1ea1i v\u00e0 Ph\u00e2n T\u00edch \u0110i\u1ec3m V\u00e0o<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 20 th\u00e1ng 8 n\u0103m 2025, BridgeBio Pharma (BBIO) \u0111ang giao d\u1ecbch \u1edf m\u1ee9c <strong>48,91 USD<\/strong> m\u1ed7i c\u1ed5 phi\u1ebfu. M\u1ee9c gi\u00e1 n\u00e0y \u0111\u1ea1i di\u1ec7n cho m\u1ed9t th\u1eddi \u0111i\u1ec3m th\u00fa v\u1ecb \u0111\u1ed1i v\u1edbi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 - c\u00f4ng ty \u0111\u00e3 ch\u1ee9ng minh ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng l\u1edbn nh\u01b0ng v\u1eabn gi\u1eef \u0111\u01b0\u1ee3c nhi\u1ec1u d\u01b0 \u0111\u1ecba t\u0103ng theo d\u1ef1 b\u00e1o c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch.<\/p> <p><strong>C\u1ea3nh B\u00e1o Ng\u00e0y Quan Tr\u1ecdng:<\/strong> H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n v\u00e0o <strong>\u0111\u1ea7u th\u00e1ng 11 n\u0103m 2025<\/strong> - th\u1eddi \u0111i\u1ec3m BridgeBio d\u1ef1 ki\u1ebfn c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp qu\u00fd 3. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c b\u1ea3n c\u1eadp nh\u1eadt h\u00e0ng qu\u00fd n\u00e0y th\u01b0\u1eddng l\u00e0 ch\u1ea5t x\u00fac t\u00e1c l\u1edbn cho bi\u1ebfn \u0111\u1ed9ng gi\u00e1.<\/p> <p><strong>Ph\u00e2n T\u00edch M\u00f4 H\u00ecnh \u1ea2nh H\u01b0\u1edfng Thu Nh\u1eadp:<\/strong><br\/> Xem x\u00e9t hi\u1ec7u su\u1ea5t g\u1ea7n \u0111\u00e2y, k\u1ebft qu\u1ea3 qu\u00fd 2 n\u0103m 2025 c\u1ee7a BridgeBio v\u00e0o ng\u00e0y 5 th\u00e1ng 8 cho th\u1ea5y l\u1ed7 r\u00f2ng tr\u00ean m\u1ed7i c\u1ed5 phi\u1ebfu l\u00e0 0,95 USD, th\u1ef1c t\u1ebf th\u1ea5p h\u01a1n k\u1ef3 v\u1ecdng 0,27 USD. Tuy nhi\u00ean, ph\u1ea3n \u1ee9ng th\u1ecb tr\u01b0\u1eddng l\u1ea1i kh\u00e1 t\u00edch c\u1ef1c v\u00ec doanh thu v\u01b0\u1ee3t d\u1ef1 b\u00e1o 15 tri\u1ec7u USD, \u0111\u1ea1t t\u1ed5ng c\u1ed9ng 110,6 tri\u1ec7u USD. M\u00f4 h\u00ecnh n\u00e0y cho th\u1ea5y c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 t\u1eadp trung nhi\u1ec1u h\u01a1n v\u00e0o t\u0103ng tr\u01b0\u1edfng doanh thu v\u00e0 s\u1ee9c h\u00fat th\u01b0\u01a1ng m\u1ea1i h\u01a1n l\u00e0 l\u1ee3i nhu\u1eadn ng\u1eafn h\u1ea1n - m\u1ed9t ch\u1ee7 \u0111\u1ec1 ph\u1ed5 bi\u1ebfn trong l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc t\u0103ng tr\u01b0\u1edfng cao.<\/p>  [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udd04 H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: T\u00e0u L\u01b0\u1ee3n C\u1ea3m X\u00fac V\u1edbi Ph\u1ea7n Th\u01b0\u1edfng<\/h2> <p>C\u1ed5 phi\u1ebfu BridgeBio \u0111\u00e3 c\u00f3 m\u1ed9t \u0111\u1ee3t t\u0103ng tr\u01b0\u1edfng tuy\u1ec7t v\u1eddi trong s\u00e1u th\u00e1ng qua, mang l\u1ea1i m\u1ed9t trong nh\u1eefng hi\u1ec7u su\u1ea5t \u1ea5n t\u01b0\u1ee3ng nh\u1ea5t trong ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc:<\/p> <ul> <li><strong>Th\u00e1ng 3 n\u0103m 2025:<\/strong> C\u1ed5 phi\u1ebfu giao d\u1ecbch trong kho\u1ea3ng 30,55-37,94 USD, k\u1ebft th\u00fac th\u00e1ng v\u1edbi m\u1ee9c gi\u1ea3m nh\u1eb9 -0,95% khi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 ti\u00eau h\u00f3a c\u00e1c kho\u1ea3n l\u1ee3i tr\u01b0\u1edbc \u0111\u00f3<a href=\"https:\/\/stockscan.io\/stocks\/BBIO\/price-history\">(StockScan)<\/a>.<\/li> <li><strong>Th\u00e1ng 4 n\u0103m 2025:<\/strong> \u0110\u00e0 t\u0103ng tr\u1edf l\u1ea1i v\u1edbi m\u1ee9c t\u0103ng m\u1ea1nh +10,96%, ph\u00e1 v\u1ee1 c\u00e1c m\u1ee9c kh\u00e1ng c\u1ef1 ch\u00ednh khi kh\u1ed1i l\u01b0\u1ee3ng giao d\u1ecbch b\u00f9ng n\u1ed5 l\u00ean 63,9 tri\u1ec7u c\u1ed5 phi\u1ebfu<a href=\"https:\/\/stockscan.io\/stocks\/BBIO\/price-history\">(StockScan)<\/a>.<\/li> <li><strong>Th\u00e1ng 5 n\u0103m 2025:<\/strong> M\u1ed9t \u0111\u1ee3t \u0111i\u1ec1u ch\u1ec9nh t\u1ea1m th\u1eddi -10,71% t\u1ea1o c\u01a1 h\u1ed9i mua v\u00e0o, v\u1edbi c\u1ed5 phi\u1ebfu t\u00ecm \u0111\u01b0\u1ee3c h\u1ed7 tr\u1ee3 quanh m\u1ee9c 31,77 USD trong b\u1ed1i c\u1ea3nh kh\u1ed1i l\u01b0\u1ee3ng cao li\u00ean t\u1ee5c<a href=\"https:\/\/stockscan.io\/stocks\/BBIO\/price-history\">(StockScan)<\/a>.<\/li> <li><strong>Th\u00e1ng 6 n\u0103m 2025:<\/strong> Th\u00e1ng n\u1ed5i b\u1eadt v\u1edbi m\u1ee9c t\u0103ng kh\u1ed5ng l\u1ed3 +26,07%, \u0111\u01b0\u1ee3c th\u00fac \u0111\u1ea9y b\u1edfi d\u1eef li\u1ec7u \u0111\u01a1n thu\u1ed1c Attruby m\u1ea1nh m\u1ebd v\u00e0 c\u00e1c c\u1eadp nh\u1eadt l\u00e2m s\u00e0ng t\u00edch c\u1ef1c<a href=\"https:\/\/stockscan.io\/stocks\/BBIO\/price-history\">(StockScan)<\/a>.<\/li> <li><strong>Th\u00e1ng 7 n\u0103m 2025:<\/strong> Ti\u1ebfp t\u1ee5c m\u1ea1nh m\u1ebd v\u1edbi m\u1ee9c t\u0103ng +8,77%, \u0111\u1ea1t m\u1ee9c cao nh\u1ea5t trong 52 tu\u1ea7n l\u00e0 48,68 USD khi s\u1ef1 quan t\u00e2m c\u1ee7a c\u00e1c t\u1ed5 ch\u1ee9c t\u0103ng l\u00ean<a href=\"https:\/\/stockscan.io\/stocks\/BBIO\/price-history\">(StockScan)<\/a>.<\/li> <li><strong>Th\u00e1ng 8 n\u0103m 2025:<\/strong> Duy tr\u00ec \u0111\u00e0 t\u0103ng quanh m\u1ee9c 49-51 USD, \u0111\u1ea1i di\u1ec7n cho m\u1ee9c <strong>t\u0103ng t\u00edch l\u0169y +67%<\/strong> t\u1eeb \u0111\u00e1y th\u00e1ng 3 \u0111\u1ebfn gi\u00e1 hi\u1ec7n t\u1ea1i<a href=\"https:\/\/stockscan.io\/stocks\/BBIO\/price-history\">(StockScan)<\/a>.<\/li> <\/ul> <p>Hi\u1ec7u su\u1ea5t n\u00e0y kh\u00f4ng ch\u1ec9 t\u1ed1t m\u00e0 c\u00f2n xu\u1ea5t s\u1eafc. BBIO \u0111\u00e3 mang l\u1ea1i <strong>l\u1ee3i nhu\u1eadn +101% trong n\u0103m qua<\/strong> trong khi th\u1ecb tr\u01b0\u1eddng chung ch\u1ec9 t\u0103ng 16,6%<a href=\"https:\/\/marketchameleon.com\/Overview\/BBIO\/Summary\/\">(Market Chameleon)<\/a>.<\/p>  <h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2> <p>D\u1ef1a tr\u00ean s\u1ef1 \u0111\u1ed3ng thu\u1eadn hi\u1ec7n t\u1ea1i c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u00e0 c\u00e1c y\u1ebfu t\u1ed1 c\u01a1 b\u1ea3n c\u1ee7a c\u00f4ng ty, \u0111\u00e2y l\u00e0 nh\u1eefng g\u00ec b\u1ea1n c\u00f3 th\u1ec3 mong \u0111\u1ee3i:<\/p> <ul> <li><strong>Cu\u1ed1i n\u0103m 2025:<\/strong> M\u1ee5c ti\u00eau trong kho\u1ea3ng <strong>52-62 USD<\/strong> - M\u1ee5c ti\u00eau gi\u00e1 \u0111\u1ed3ng thu\u1eadn l\u00e0 61,69 USD (t\u0103ng 24,22%) v\u1edbi m\u1ed9t s\u1ed1 nh\u00e0 ph\u00e2n t\u00edch d\u1ef1 b\u00e1o l\u00ean t\u1edbi 95 USD<a href=\"https:\/\/stockanalysis.com\/stocks\/bbio\/forecast\/\">(Stock Analysis)<\/a>. \u2192 <strong>MUA M\u1ea0NH<\/strong><\/li> <li><strong>D\u1ef1 b\u00e1o 2026:<\/strong> Kho\u1ea3ng <strong>44-52 USD<\/strong> - C\u00f3 s\u1ef1 ph\u00e2n h\u00f3a v\u1edbi \u01b0\u1edbc t\u00ednh t\u1eeb 35,01 \u0111\u1ebfn 50,36 USD, ph\u1ea3n \u00e1nh s\u1ef1 bi\u1ebfn \u0111\u1ed9ng \u0111i\u1ec3n h\u00ecnh c\u1ee7a c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<a href=\"https:\/\/altindex.com\/ticker\/bbio\/price-prediction\">(AltIndex)<\/a>.<\/li> <li><strong>Tri\u1ec3n v\u1ecdng 2028:<\/strong> M\u1eb7c d\u00f9 c\u00e1c d\u1ef1 b\u00e1o c\u1ee5 th\u1ec3 cho n\u0103m 2028 kh\u00f4ng \u0111\u01b0\u1ee3c c\u00f4ng b\u1ed1 r\u1ed9ng r\u00e3i, xu h\u01b0\u1edbng cho th\u1ea5y ti\u1ec1m n\u0103ng <strong>55-70 USD<\/strong> n\u1ebfu th\u00e0nh c\u00f4ng th\u01b0\u01a1ng m\u1ea1i hi\u1ec7n t\u1ea1i ti\u1ebfp t\u1ee5c.<\/li> <li><strong>D\u00e0i h\u1ea1n 2030:<\/strong> Kho\u1ea3ng <strong>22-36 USD<\/strong> - D\u1ef1 b\u00e1o d\u00e0i h\u1ea1n cho th\u1ea5y s\u1ef1 n\u00e9n gi\u00e1 do lo ng\u1ea1i v\u1ec1 b\u1eb1ng s\u00e1ng ch\u1ebf v\u00e0 c\u1ea1nh tranh, nh\u01b0ng \u0111\u00e2y v\u1eabn l\u00e0 m\u1ee9c l\u1ee3i nhu\u1eadn tuy\u1ec7t v\u1eddi so v\u1edbi m\u1ee9c hi\u1ec7n t\u1ea1i<a href=\"https:\/\/gov.capital\/stock\/bbio-stock\/\">(Gov Capital)<\/a>.<\/li> <\/ul> <p>B\u00e0i h\u1ecdc ch\u00ednh? \u0110\u00e0 t\u0103ng ng\u1eafn h\u1ea1n r\u1ea5t m\u1ea1nh, khi\u1ebfn hi\u1ec7n t\u1ea1i l\u00e0 th\u1eddi \u0111i\u1ec3m tuy\u1ec7t v\u1eddi \u0111\u1ec3 v\u00e0o l\u1ec7nh cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 tho\u1ea3i m\u00e1i v\u1edbi s\u1ef1 bi\u1ebfn \u0111\u1ed9ng c\u1ee7a c\u00f4ng ngh\u1ec7 sinh h\u1ecdc.<\/p>  <h2>\u26a0\ufe0f \u0110\u00e1nh Gi\u00e1 R\u1ee7i Ro: Nh\u1eefng \u0110i\u1ec1u C\u00f3 Th\u1ec3 Sai<\/h2> <ul> <li><strong>R\u1ee7i Ro Bi\u1ebfn \u0110\u1ed9ng Cao:<\/strong> BBIO c\u00f3 h\u1ec7 s\u1ed1 beta t\u1eeb 0,88 \u0111\u1ebfn 0,94, ngh\u0129a l\u00e0 c\u1ed5 phi\u1ebfu c\u00f3 th\u1ec3 dao \u0111\u1ed9ng m\u1ea1nh theo tin t\u1ee9c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng ho\u1eb7c quy\u1ebft \u0111\u1ecbnh qu\u1ea3n l\u00fd<a href=\"https:\/\/marketchameleon.com\/Overview\/BBIO\/Summary\/\">(Market Chameleon)<\/a>. M\u1ed9t th\u1eed nghi\u1ec7m th\u1ea5t b\u1ea1i c\u00f3 th\u1ec3 khi\u1ebfn c\u1ed5 phi\u1ebfu gi\u1ea3m 30-50% ch\u1ec9 trong v\u00e0i ng\u00e0y.<\/li> <li><strong>Ph\u1ee5 Thu\u1ed9c V\u00e0o Quy \u0110\u1ecbnh:<\/strong> To\u00e0n b\u1ed9 ho\u1ea1t \u0111\u1ed9ng kinh doanh ph\u1ee5 thu\u1ed9c v\u00e0o s\u1ef1 ch\u1ea5p thu\u1eadn c\u1ee7a FDA v\u00e0 EMA. B\u1ea5t k\u1ef3 s\u1ef1 ch\u1eadm tr\u1ec5 ho\u1eb7c t\u1eeb ch\u1ed1i n\u00e0o \u0111\u1ed1i v\u1edbi c\u00e1c thu\u1ed1c trong pipeline s\u1ebd l\u00e0 th\u1ea3m h\u1ecda.<\/li> <li><strong>Lo Ng\u1ea1i V\u1ec1 Ti\u00eau Hao Ti\u1ec1n M\u1eb7t:<\/strong> M\u1eb7c d\u00f9 doanh thu g\u1ea7n \u0111\u00e2y t\u0103ng tr\u01b0\u1edfng, c\u00f4ng ty v\u1eabn b\u00e1o l\u1ed7 0,95 USD tr\u00ean m\u1ed7i c\u1ed5 phi\u1ebfu trong qu\u00fd tr\u01b0\u1edbc. H\u1ecd c\u1ea7n th\u00e0nh c\u00f4ng th\u01b0\u01a1ng m\u1ea1i li\u00ean t\u1ee5c \u0111\u1ec3 \u0111\u1ea1t l\u1ee3i nhu\u1eadn<a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/08\/05\/3127793\/0\/en\/BridgeBio-Reports-Second-Quarter-2025-Financial-Results-and-Business-Updates.html\">(Globe Newswire)<\/a>.<\/li> <li><strong>C\u1ea1nh Tranh Gia T\u0103ng:<\/strong> C\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn h\u01a1n ng\u00e0y c\u00e0ng nh\u1eafm v\u00e0o c\u00e1c b\u1ec7nh di truy\u1ec1n hi\u1ebfm, c\u00f3 th\u1ec3 l\u00e0m gi\u1ea3m l\u1ee3i th\u1ebf \u0111i \u0111\u1ea7u c\u1ee7a BridgeBio.<\/li> <\/ul>  <h2>\ud83d\udfe2 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c: T\u1ea1i Sao L\u1eadp Lu\u1eadn T\u0103ng Gi\u00e1 M\u1ea1nh M\u1ebd<\/h2> <ul> <li><strong>S\u1ee9c H\u00fat Th\u01b0\u01a1ng M\u1ea1i:<\/strong> Attruby t\u1ea1o ra 71,5 tri\u1ec7u USD doanh thu s\u1ea3n ph\u1ea9m r\u00f2ng trong qu\u00fd 2 n\u0103m 2025 v\u1edbi 3.751 \u0111\u01a1n thu\u1ed1c \u0111\u1ed9c nh\u1ea5t \u0111\u00e3 \u0111\u01b0\u1ee3c k\u00ea - g\u1ea7n nh\u01b0 t\u0103ng g\u1ea5p \u0111\u00f4i so v\u1edbi qu\u00fd tr\u01b0\u1edbc<a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/08\/05\/3127793\/0\/en\/BridgeBio-Reports-Second-Quarter-2025-Financial-Results-and-Business-Updates.html\">(Globe Newswire)<\/a>.<\/li> <li><strong>S\u1ee9c M\u1ea1nh T\u00e0i Ch\u00ednh:<\/strong> V\u1ecb th\u1ebf ti\u1ec1n m\u1eb7t 540,6 tri\u1ec7u USD c\u00f9ng v\u1edbi 300 tri\u1ec7u USD t\u1eeb vi\u1ec7c chuy\u1ec3n nh\u01b0\u1ee3ng b\u1ea3n quy\u1ec1n g\u1ea7n \u0111\u00e2y cung c\u1ea5p ngu\u1ed3n l\u1ef1c l\u1edbn cho ph\u00e1t tri\u1ec3n<a href=\"https:\/\/investor.bridgebio.com\/news\/news-details\/2025\/BridgeBio-Raises-300-Million-Through-Partial-Capped-Monetization-of-BEYONTTRA-European-Royalty\/default.aspx\">(BridgeBio Investor)<\/a>.<\/li> <li><strong>\u0110\u1ed9 S\u00e2u Pipeline:<\/strong> Nhi\u1ec1u ch\u01b0\u01a1ng tr\u00ecnh Giai \u0111o\u1ea1n 3 bao g\u1ed3m BBP-418 \u0111\u00e3 ho\u00e0n t\u1ea5t tuy\u1ec3n d\u1ee5ng tr\u01b0\u1edbc k\u1ebf ho\u1ea1ch, t\u1ea1o ra nhi\u1ec1u ch\u1ea5t x\u00fac t\u00e1c ti\u1ec1m n\u0103ng<a href=\"https:\/\/investor.bridgebio.com\/overview\/default.aspx\">(BridgeBio Overview)<\/a>.<\/li> <li><strong>H\u1ed7 Tr\u1ee3 T\u1eeb Nh\u00e0 Ph\u00e2n T\u00edch:<\/strong> 16 nh\u00e0 ph\u00e2n t\u00edch theo d\u00f5i BBIO v\u1edbi 7 khuy\u1ebfn ngh\u1ecb Mua M\u1ea1nh v\u00e0 9 khuy\u1ebfn ngh\u1ecb Mua - kh\u00f4ng c\u00f3 khuy\u1ebfn ngh\u1ecb Gi\u1eef ho\u1eb7c B\u00e1n n\u00e0o<a href=\"https:\/\/stockanalysis.com\/stocks\/bbio\/forecast\/\">(Stock Analysis)<\/a>.<\/li> <\/ul>  <h2>\ud83c\udfaf K\u1ebf Ho\u1ea1ch H\u00e0nh \u0110\u1ed9ng Cho Nh\u00e0 Giao D\u1ecbch M\u1edbi<\/h2> <p><strong>Nh\u1eefng b\u01b0\u1edbc \u0111i th\u00f4ng minh h\u00f4m nay:<\/strong><\/p> <ol> <li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf:<\/strong> Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 3-5% danh m\u1ee5c \u0111\u1ea7u t\u01b0 cho BBIO ban \u0111\u1ea7u - c\u00f4ng ngh\u1ec7 sinh h\u1ecdc v\u1ed1n c\u00f3 r\u1ee7i ro cao<\/li> <li><strong>Trung b\u00ecnh gi\u00e1 mua:<\/strong> C\u00e2n nh\u1eafc mua theo t\u1eebng ph\u1ea7n thay v\u00ec m\u1ed9t l\u1ea7n \u0111\u1ec3 gi\u1ea3m thi\u1ec3u bi\u1ebfn \u0111\u1ed9ng<\/li> <li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o cho th\u00e1ng 11:<\/strong> \u0110\u00e1nh d\u1ea5u l\u1ecbch cho b\u00e1o c\u00e1o thu nh\u1eadp qu\u00fd 3 - \u0111\u00e2y c\u00f3 th\u1ec3 l\u00e0 \u0111i\u1ec3m v\u00e0o t\u1ed1t nh\u1ea5t n\u1ebfu c\u00f3 s\u1ef1 gi\u1ea3m gi\u00e1 sau b\u00e1o c\u00e1o<\/li> <li><strong>Gi\u00e1m s\u00e1t kh\u1ed1i l\u01b0\u1ee3ng:<\/strong> C\u00e1c ng\u00e0y c\u00f3 kh\u1ed1i l\u01b0\u1ee3ng cao th\u01b0\u1eddng b\u00e1o hi\u1ec7u c\u00e1c bi\u1ebfn \u0111\u1ed9ng l\u1edbn - d\u00f9ng ch\u00fang l\u00e0m t\u00edn hi\u1ec7u v\u00e0o l\u1ec7nh b\u1ed5 sung<\/li> <\/ol> <p><strong>Ch\u00e2m ng\u00f4n h\u00e0i h\u01b0\u1edbc t\u1eeb ng\u01b0\u1eddi c\u00f3 kinh nghi\u1ec7m:<\/strong> \"Giao d\u1ecbch BBIO gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc xu\u1ea5t s\u1eafc - c\u1ef1c k\u1ef3 b\u1ed5 \u00edch nh\u01b0ng d\u1ec5 c\u00f3 nh\u1eefng bi\u1ebfn \u0111\u1ed9ng t\u00e2m tr\u1ea1ng m\u1ea1nh d\u1ef1a tr\u00ean k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m. \u0110\u1eebng c\u1ea7u h\u00f4n ngay bu\u1ed5i h\u1eb9n \u0111\u1ea7u!\"<\/p>  <h2>\u2705 H\u01b0\u1edbng D\u1eabn T\u1eebng B\u01b0\u1edbc: C\u00e1ch Mua C\u1ed5 Phi\u1ebfu BridgeBio Pharma, Inc. (BBIO)<\/h2> <table> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0110\u1ed9ng<\/th><th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn N\u1ec1n T\u1ea3ng Giao D\u1ecbch<\/td><td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng c\u00f3 truy c\u1eadp NASDAQ v\u00e0 ph\u00ed hoa h\u1ed3ng h\u1ee3p l\u00fd<\/td><\/tr> <tr><td>2<\/td><td>Ho\u00e0n Th\u00e0nh N\u1ea1p Ti\u1ec1n V\u00e0o T\u00e0i Kho\u1ea3n<\/td><td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i r\u1ee7i ro - ngay c\u1ea3 100 USD c\u0169ng c\u00f3 th\u1ec3 gi\u00fap b\u1ea1n b\u1eaft \u0111\u1ea7u<\/td><\/tr> <tr><td>3<\/td><td>T\u00ecm ki\u1ebfm \"BBIO\"<\/td><td>S\u1eed d\u1ee5ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ph\u1ea3i t\u00ean c\u00f4ng ty, \u0111\u1ec3 c\u00f3 k\u1ebft qu\u1ea3 ch\u00ednh x\u00e1c<\/td><\/tr> <tr><td>4<\/td><td>Ch\u1ecdn Lo\u1ea1i L\u1ec7nh<\/td><td>D\u00f9ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o thay v\u00ec l\u1ec7nh th\u1ecb tr\u01b0\u1eddng<\/td><\/tr> <tr><td>5<\/td><td>Xem l\u1ea1i v\u00e0 X\u00e1c nh\u1eadn<\/td><td>Ki\u1ec3m tra k\u1ef9 c\u00e1c chi ti\u1ebft l\u1ec7nh v\u00e0 ph\u00ed tr\u01b0\u1edbc khi ho\u00e0n t\u1ea5t<\/td><\/tr> <\/tbody> <\/table>  <h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option L\u00e0 L\u1ef1a Ch\u1ecdn H\u1ee3p L\u00fd Cho Giao D\u1ecbch BBIO<\/h2> <p>\u0110\u1ed1i v\u1edbi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 mu\u1ed1n giao d\u1ecbch c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO), Pocket Option cung c\u1ea5p nhi\u1ec1u l\u1ee3i th\u1ebf n\u1ed5i b\u1eadt ph\u00f9 h\u1ee3p ho\u00e0n h\u1ea3o v\u1edbi \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc:<\/p> <ul> <li><strong>Ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u linh ho\u1ea1t:<\/strong> Ch\u1ec9 c\u1ea7n 5 USD \u0111\u1ec3 b\u1eaft \u0111\u1ea7u, b\u1ea1n c\u00f3 th\u1ec3 th\u1eed nghi\u1ec7m c\u00e1c chi\u1ebfn l\u01b0\u1ee3c v\u1edbi r\u1ee7i ro t\u1ed1i thi\u1ec3u tr\u01b0\u1edbc khi cam k\u1ebft s\u1ed1 ti\u1ec1n l\u1edbn h\u01a1n v\u00e0o l\u0129nh v\u1ef1c bi\u1ebfn \u0111\u1ed9ng n\u00e0y.<\/li> <li><strong>X\u00e1c minh t\u00e0i kho\u1ea3n nhanh ch\u00f3ng:<\/strong> Quy tr\u00ecnh KYC ch\u1ec9 m\u1ea5t 1 ph\u00fat gi\u00fap b\u1ea1n t\u1eadn d\u1ee5ng tin t\u1ee9c n\u00f3ng ho\u1eb7c bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u1ed9t ng\u1ed9t m\u00e0 kh\u00f4ng ph\u1ea3i ch\u1edd \u0111\u1ee3i nhi\u1ec1u ng\u00e0y \u0111\u1ec3 \u0111\u01b0\u1ee3c duy\u1ec7t t\u00e0i kho\u1ea3n.<\/li> <li><strong>Nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n:<\/strong> H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n \u0111\u1ea3m b\u1ea3o b\u1ea1n c\u00f3 th\u1ec3 nhanh ch\u00f3ng ti\u1ebfp c\u1eadn l\u1ee3i nhu\u1eadn khi BBIO c\u00f3 nh\u1eefng \u0111\u1ee3t t\u0103ng gi\u00e1 \u0111\u1eb7c tr\u01b0ng c\u1ee7a c\u00f4ng ngh\u1ec7 sinh h\u1ecdc.<\/li> <\/ul> <p>C\u1ea5u tr\u00fac n\u1ec1n t\u1ea3ng n\u00e0y \u0111\u1eb7c bi\u1ec7t c\u00f3 gi\u00e1 tr\u1ecb cho giao d\u1ecbch c\u00e1c c\u1ed5 phi\u1ebfu nh\u01b0 BBIO c\u00f3 th\u1ec3 bi\u1ebfn \u0111\u1ed9ng 10-20% ch\u1ec9 trong m\u1ed9t s\u1ef1 ki\u1ec7n tin t\u1ee9c, cho ph\u00e9p b\u1ea1n v\u00e0o v\u00e0 tho\u00e1t v\u1ecb th\u1ebf v\u1edbi s\u1ef1 linh ho\u1ea1t t\u1ed1i \u0111a.<\/p>  <h2>\ud83e\uddec BridgeBio N\u0103m 2025: Ti\u00ean Phong Y H\u1ecdc Di Truy\u1ec1n<\/h2> <p>BridgeBio Pharma \u0111\u00e3 kh\u1eb3ng \u0111\u1ecbnh m\u00ecnh l\u00e0 m\u1ed9t c\u00f4ng ty d\u01b0\u1ee3c ph\u1ea9m giai \u0111o\u1ea1n th\u01b0\u01a1ng m\u1ea1i t\u1eadp trung ho\u00e0n to\u00e0n v\u00e0o ph\u00e1t tri\u1ec3n c\u00e1c lo\u1ea1i thu\u1ed1c chuy\u1ec3n \u0111\u1ed5i cho c\u00e1c b\u1ec7nh di truy\u1ec1n v\u00e0 m\u1ed9t s\u1ed1 lo\u1ea1i ung th\u01b0<a href=\"https:\/\/investor.bridgebio.com\/overview\/default.aspx\">(BridgeBio Overview)<\/a>. Th\u00e0nh l\u1eadp n\u0103m 2015, c\u00f4ng ty ho\u1ea1t \u0111\u1ed9ng to\u00e0n c\u1ea7u v\u1edbi s\u1ef1 hi\u1ec7n di\u1ec7n t\u1ea1i B\u1eafc M\u1ef9 v\u00e0 ch\u00e2u \u00c2u.<\/p> <p>M\u00f4 h\u00ecnh kinh doanh c\u1ee7a c\u00f4ng ty k\u1ebft h\u1ee3p ph\u00e1t hi\u1ec7n thu\u1ed1c n\u1ed9i b\u1ed9 v\u1edbi c\u00e1c \u0111\u1ed1i t\u00e1c chi\u1ebfn l\u01b0\u1ee3c, hi\u1ec7n \u0111ang ti\u1ebfp th\u1ecb b\u1ed1n lo\u1ea1i thu\u1ed1c \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t trong khi duy tr\u00ec m\u1ed9t pipeline m\u1ea1nh m\u1ebd bao g\u1ed3m c\u00e1c l\u0129nh v\u1ef1c tim th\u1eadn ch\u00ednh x\u00e1c, b\u1ec7nh di truy\u1ec1n Mendelian, ung th\u01b0 ch\u00ednh x\u00e1c v\u00e0 li\u1ec7u ph\u00e1p gen<a href=\"https:\/\/investor.bridgebio.com\/overview\/default.aspx\">(BridgeBio Overview)<\/a>.<\/p> <p><strong>S\u1ef1 ki\u1ec7n th\u00fa v\u1ecb n\u0103m 2025<\/strong>: Thu\u1ed1c Attruby c\u1ee7a BridgeBio \u0111\u00e3 \u0111\u1ea1t \u0111\u01b0\u1ee3c \u0111i\u1ec1u \u0111\u00e1ng ch\u00fa \u00fd - t\u1ea1o ra 3.751 \u0111\u01a1n thu\u1ed1c b\u1ec7nh nh\u00e2n \u0111\u1ed9c nh\u1ea5t ch\u1ec9 trong ch\u00edn th\u00e1ng k\u1ec3 t\u1eeb khi \u0111\u01b0\u1ee3c FDA ph\u00ea duy\u1ec7t, v\u1edbi t\u1ed1c \u0111\u1ed9 \u00e1p d\u1ee5ng g\u1ea7n nh\u01b0 t\u0103ng g\u1ea5p \u0111\u00f4i theo t\u1eebng qu\u00fd<a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/08\/05\/3127793\/0\/en\/BridgeBio-Reports-Second-Quarter-2025-Financial-Results-and-Business-Updates.html\">(Globe Newswire)<\/a>. T\u1ed1c \u0111\u1ed9 th\u01b0\u01a1ng m\u1ea1i n\u00e0y g\u1ea7n nh\u01b0 ch\u01b0a t\u1eebng c\u00f3 trong l\u0129nh v\u1ef1c b\u1ec7nh hi\u1ebfm v\u00e0 th\u1ec3 hi\u1ec7n c\u1ea3 nhu c\u1ea7u y t\u1ebf v\u00e0 s\u1ef1 xu\u1ea5t s\u1eafc trong th\u1ef1c thi.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 V\u1ecb Tr\u00ed Th\u1ecb Tr\u01b0\u1eddng Hi\u1ec7n T\u1ea1i v\u00e0 Ph\u00e2n T\u00edch \u0110i\u1ec3m V\u00e0o<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 20 th\u00e1ng 8 n\u0103m 2025, BridgeBio Pharma (BBIO) \u0111ang giao d\u1ecbch \u1edf m\u1ee9c <strong>48,91 USD<\/strong> m\u1ed7i c\u1ed5 phi\u1ebfu. M\u1ee9c gi\u00e1 n\u00e0y \u0111\u1ea1i di\u1ec7n cho m\u1ed9t th\u1eddi \u0111i\u1ec3m th\u00fa v\u1ecb \u0111\u1ed1i v\u1edbi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 &#8211; c\u00f4ng ty \u0111\u00e3 ch\u1ee9ng minh ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng l\u1edbn nh\u01b0ng v\u1eabn gi\u1eef \u0111\u01b0\u1ee3c nhi\u1ec1u d\u01b0 \u0111\u1ecba t\u0103ng theo d\u1ef1 b\u00e1o c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch.<\/p>\n<p><strong>C\u1ea3nh B\u00e1o Ng\u00e0y Quan Tr\u1ecdng:<\/strong> H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n v\u00e0o <strong>\u0111\u1ea7u th\u00e1ng 11 n\u0103m 2025<\/strong> &#8211; th\u1eddi \u0111i\u1ec3m BridgeBio d\u1ef1 ki\u1ebfn c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp qu\u00fd 3. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c b\u1ea3n c\u1eadp nh\u1eadt h\u00e0ng qu\u00fd n\u00e0y th\u01b0\u1eddng l\u00e0 ch\u1ea5t x\u00fac t\u00e1c l\u1edbn cho bi\u1ebfn \u0111\u1ed9ng gi\u00e1.<\/p>\n<p><strong>Ph\u00e2n T\u00edch M\u00f4 H\u00ecnh \u1ea2nh H\u01b0\u1edfng Thu Nh\u1eadp:<\/strong><br \/> Xem x\u00e9t hi\u1ec7u su\u1ea5t g\u1ea7n \u0111\u00e2y, k\u1ebft qu\u1ea3 qu\u00fd 2 n\u0103m 2025 c\u1ee7a BridgeBio v\u00e0o ng\u00e0y 5 th\u00e1ng 8 cho th\u1ea5y l\u1ed7 r\u00f2ng tr\u00ean m\u1ed7i c\u1ed5 phi\u1ebfu l\u00e0 0,95 USD, th\u1ef1c t\u1ebf th\u1ea5p h\u01a1n k\u1ef3 v\u1ecdng 0,27 USD. Tuy nhi\u00ean, ph\u1ea3n \u1ee9ng th\u1ecb tr\u01b0\u1eddng l\u1ea1i kh\u00e1 t\u00edch c\u1ef1c v\u00ec doanh thu v\u01b0\u1ee3t d\u1ef1 b\u00e1o 15 tri\u1ec7u USD, \u0111\u1ea1t t\u1ed5ng c\u1ed9ng 110,6 tri\u1ec7u USD. M\u00f4 h\u00ecnh n\u00e0y cho th\u1ea5y c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 t\u1eadp trung nhi\u1ec1u h\u01a1n v\u00e0o t\u0103ng tr\u01b0\u1edfng doanh thu v\u00e0 s\u1ee9c h\u00fat th\u01b0\u01a1ng m\u1ea1i h\u01a1n l\u00e0 l\u1ee3i nhu\u1eadn ng\u1eafn h\u1ea1n &#8211; m\u1ed9t ch\u1ee7 \u0111\u1ec1 ph\u1ed5 bi\u1ebfn trong l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc t\u0103ng tr\u01b0\u1edfng cao.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd04 H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: T\u00e0u L\u01b0\u1ee3n C\u1ea3m X\u00fac V\u1edbi Ph\u1ea7n Th\u01b0\u1edfng<\/h2>\n<p>C\u1ed5 phi\u1ebfu BridgeBio \u0111\u00e3 c\u00f3 m\u1ed9t \u0111\u1ee3t t\u0103ng tr\u01b0\u1edfng tuy\u1ec7t v\u1eddi trong s\u00e1u th\u00e1ng qua, mang l\u1ea1i m\u1ed9t trong nh\u1eefng hi\u1ec7u su\u1ea5t \u1ea5n t\u01b0\u1ee3ng nh\u1ea5t trong ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc:<\/p>\n<ul>\n<li><strong>Th\u00e1ng 3 n\u0103m 2025:<\/strong> C\u1ed5 phi\u1ebfu giao d\u1ecbch trong kho\u1ea3ng 30,55-37,94 USD, k\u1ebft th\u00fac th\u00e1ng v\u1edbi m\u1ee9c gi\u1ea3m nh\u1eb9 -0,95% khi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 ti\u00eau h\u00f3a c\u00e1c kho\u1ea3n l\u1ee3i tr\u01b0\u1edbc \u0111\u00f3<a href=\"https:\/\/stockscan.io\/stocks\/BBIO\/price-history\">(StockScan)<\/a>.<\/li>\n<li><strong>Th\u00e1ng 4 n\u0103m 2025:<\/strong> \u0110\u00e0 t\u0103ng tr\u1edf l\u1ea1i v\u1edbi m\u1ee9c t\u0103ng m\u1ea1nh +10,96%, ph\u00e1 v\u1ee1 c\u00e1c m\u1ee9c kh\u00e1ng c\u1ef1 ch\u00ednh khi kh\u1ed1i l\u01b0\u1ee3ng giao d\u1ecbch b\u00f9ng n\u1ed5 l\u00ean 63,9 tri\u1ec7u c\u1ed5 phi\u1ebfu<a href=\"https:\/\/stockscan.io\/stocks\/BBIO\/price-history\">(StockScan)<\/a>.<\/li>\n<li><strong>Th\u00e1ng 5 n\u0103m 2025:<\/strong> M\u1ed9t \u0111\u1ee3t \u0111i\u1ec1u ch\u1ec9nh t\u1ea1m th\u1eddi -10,71% t\u1ea1o c\u01a1 h\u1ed9i mua v\u00e0o, v\u1edbi c\u1ed5 phi\u1ebfu t\u00ecm \u0111\u01b0\u1ee3c h\u1ed7 tr\u1ee3 quanh m\u1ee9c 31,77 USD trong b\u1ed1i c\u1ea3nh kh\u1ed1i l\u01b0\u1ee3ng cao li\u00ean t\u1ee5c<a href=\"https:\/\/stockscan.io\/stocks\/BBIO\/price-history\">(StockScan)<\/a>.<\/li>\n<li><strong>Th\u00e1ng 6 n\u0103m 2025:<\/strong> Th\u00e1ng n\u1ed5i b\u1eadt v\u1edbi m\u1ee9c t\u0103ng kh\u1ed5ng l\u1ed3 +26,07%, \u0111\u01b0\u1ee3c th\u00fac \u0111\u1ea9y b\u1edfi d\u1eef li\u1ec7u \u0111\u01a1n thu\u1ed1c Attruby m\u1ea1nh m\u1ebd v\u00e0 c\u00e1c c\u1eadp nh\u1eadt l\u00e2m s\u00e0ng t\u00edch c\u1ef1c<a href=\"https:\/\/stockscan.io\/stocks\/BBIO\/price-history\">(StockScan)<\/a>.<\/li>\n<li><strong>Th\u00e1ng 7 n\u0103m 2025:<\/strong> Ti\u1ebfp t\u1ee5c m\u1ea1nh m\u1ebd v\u1edbi m\u1ee9c t\u0103ng +8,77%, \u0111\u1ea1t m\u1ee9c cao nh\u1ea5t trong 52 tu\u1ea7n l\u00e0 48,68 USD khi s\u1ef1 quan t\u00e2m c\u1ee7a c\u00e1c t\u1ed5 ch\u1ee9c t\u0103ng l\u00ean<a href=\"https:\/\/stockscan.io\/stocks\/BBIO\/price-history\">(StockScan)<\/a>.<\/li>\n<li><strong>Th\u00e1ng 8 n\u0103m 2025:<\/strong> Duy tr\u00ec \u0111\u00e0 t\u0103ng quanh m\u1ee9c 49-51 USD, \u0111\u1ea1i di\u1ec7n cho m\u1ee9c <strong>t\u0103ng t\u00edch l\u0169y +67%<\/strong> t\u1eeb \u0111\u00e1y th\u00e1ng 3 \u0111\u1ebfn gi\u00e1 hi\u1ec7n t\u1ea1i<a href=\"https:\/\/stockscan.io\/stocks\/BBIO\/price-history\">(StockScan)<\/a>.<\/li>\n<\/ul>\n<p>Hi\u1ec7u su\u1ea5t n\u00e0y kh\u00f4ng ch\u1ec9 t\u1ed1t m\u00e0 c\u00f2n xu\u1ea5t s\u1eafc. BBIO \u0111\u00e3 mang l\u1ea1i <strong>l\u1ee3i nhu\u1eadn +101% trong n\u0103m qua<\/strong> trong khi th\u1ecb tr\u01b0\u1eddng chung ch\u1ec9 t\u0103ng 16,6%<a href=\"https:\/\/marketchameleon.com\/Overview\/BBIO\/Summary\/\">(Market Chameleon)<\/a>.<\/p>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2>\n<p>D\u1ef1a tr\u00ean s\u1ef1 \u0111\u1ed3ng thu\u1eadn hi\u1ec7n t\u1ea1i c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u00e0 c\u00e1c y\u1ebfu t\u1ed1 c\u01a1 b\u1ea3n c\u1ee7a c\u00f4ng ty, \u0111\u00e2y l\u00e0 nh\u1eefng g\u00ec b\u1ea1n c\u00f3 th\u1ec3 mong \u0111\u1ee3i:<\/p>\n<ul>\n<li><strong>Cu\u1ed1i n\u0103m 2025:<\/strong> M\u1ee5c ti\u00eau trong kho\u1ea3ng <strong>52-62 USD<\/strong> &#8211; M\u1ee5c ti\u00eau gi\u00e1 \u0111\u1ed3ng thu\u1eadn l\u00e0 61,69 USD (t\u0103ng 24,22%) v\u1edbi m\u1ed9t s\u1ed1 nh\u00e0 ph\u00e2n t\u00edch d\u1ef1 b\u00e1o l\u00ean t\u1edbi 95 USD<a href=\"https:\/\/stockanalysis.com\/stocks\/bbio\/forecast\/\">(Stock Analysis)<\/a>. \u2192 <strong>MUA M\u1ea0NH<\/strong><\/li>\n<li><strong>D\u1ef1 b\u00e1o 2026:<\/strong> Kho\u1ea3ng <strong>44-52 USD<\/strong> &#8211; C\u00f3 s\u1ef1 ph\u00e2n h\u00f3a v\u1edbi \u01b0\u1edbc t\u00ednh t\u1eeb 35,01 \u0111\u1ebfn 50,36 USD, ph\u1ea3n \u00e1nh s\u1ef1 bi\u1ebfn \u0111\u1ed9ng \u0111i\u1ec3n h\u00ecnh c\u1ee7a c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<a href=\"https:\/\/altindex.com\/ticker\/bbio\/price-prediction\">(AltIndex)<\/a>.<\/li>\n<li><strong>Tri\u1ec3n v\u1ecdng 2028:<\/strong> M\u1eb7c d\u00f9 c\u00e1c d\u1ef1 b\u00e1o c\u1ee5 th\u1ec3 cho n\u0103m 2028 kh\u00f4ng \u0111\u01b0\u1ee3c c\u00f4ng b\u1ed1 r\u1ed9ng r\u00e3i, xu h\u01b0\u1edbng cho th\u1ea5y ti\u1ec1m n\u0103ng <strong>55-70 USD<\/strong> n\u1ebfu th\u00e0nh c\u00f4ng th\u01b0\u01a1ng m\u1ea1i hi\u1ec7n t\u1ea1i ti\u1ebfp t\u1ee5c.<\/li>\n<li><strong>D\u00e0i h\u1ea1n 2030:<\/strong> Kho\u1ea3ng <strong>22-36 USD<\/strong> &#8211; D\u1ef1 b\u00e1o d\u00e0i h\u1ea1n cho th\u1ea5y s\u1ef1 n\u00e9n gi\u00e1 do lo ng\u1ea1i v\u1ec1 b\u1eb1ng s\u00e1ng ch\u1ebf v\u00e0 c\u1ea1nh tranh, nh\u01b0ng \u0111\u00e2y v\u1eabn l\u00e0 m\u1ee9c l\u1ee3i nhu\u1eadn tuy\u1ec7t v\u1eddi so v\u1edbi m\u1ee9c hi\u1ec7n t\u1ea1i<a href=\"https:\/\/gov.capital\/stock\/bbio-stock\/\">(Gov Capital)<\/a>.<\/li>\n<\/ul>\n<p>B\u00e0i h\u1ecdc ch\u00ednh? \u0110\u00e0 t\u0103ng ng\u1eafn h\u1ea1n r\u1ea5t m\u1ea1nh, khi\u1ebfn hi\u1ec7n t\u1ea1i l\u00e0 th\u1eddi \u0111i\u1ec3m tuy\u1ec7t v\u1eddi \u0111\u1ec3 v\u00e0o l\u1ec7nh cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 tho\u1ea3i m\u00e1i v\u1edbi s\u1ef1 bi\u1ebfn \u0111\u1ed9ng c\u1ee7a c\u00f4ng ngh\u1ec7 sinh h\u1ecdc.<\/p>\n<h2>\u26a0\ufe0f \u0110\u00e1nh Gi\u00e1 R\u1ee7i Ro: Nh\u1eefng \u0110i\u1ec1u C\u00f3 Th\u1ec3 Sai<\/h2>\n<ul>\n<li><strong>R\u1ee7i Ro Bi\u1ebfn \u0110\u1ed9ng Cao:<\/strong> BBIO c\u00f3 h\u1ec7 s\u1ed1 beta t\u1eeb 0,88 \u0111\u1ebfn 0,94, ngh\u0129a l\u00e0 c\u1ed5 phi\u1ebfu c\u00f3 th\u1ec3 dao \u0111\u1ed9ng m\u1ea1nh theo tin t\u1ee9c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng ho\u1eb7c quy\u1ebft \u0111\u1ecbnh qu\u1ea3n l\u00fd<a href=\"https:\/\/marketchameleon.com\/Overview\/BBIO\/Summary\/\">(Market Chameleon)<\/a>. M\u1ed9t th\u1eed nghi\u1ec7m th\u1ea5t b\u1ea1i c\u00f3 th\u1ec3 khi\u1ebfn c\u1ed5 phi\u1ebfu gi\u1ea3m 30-50% ch\u1ec9 trong v\u00e0i ng\u00e0y.<\/li>\n<li><strong>Ph\u1ee5 Thu\u1ed9c V\u00e0o Quy \u0110\u1ecbnh:<\/strong> To\u00e0n b\u1ed9 ho\u1ea1t \u0111\u1ed9ng kinh doanh ph\u1ee5 thu\u1ed9c v\u00e0o s\u1ef1 ch\u1ea5p thu\u1eadn c\u1ee7a FDA v\u00e0 EMA. B\u1ea5t k\u1ef3 s\u1ef1 ch\u1eadm tr\u1ec5 ho\u1eb7c t\u1eeb ch\u1ed1i n\u00e0o \u0111\u1ed1i v\u1edbi c\u00e1c thu\u1ed1c trong pipeline s\u1ebd l\u00e0 th\u1ea3m h\u1ecda.<\/li>\n<li><strong>Lo Ng\u1ea1i V\u1ec1 Ti\u00eau Hao Ti\u1ec1n M\u1eb7t:<\/strong> M\u1eb7c d\u00f9 doanh thu g\u1ea7n \u0111\u00e2y t\u0103ng tr\u01b0\u1edfng, c\u00f4ng ty v\u1eabn b\u00e1o l\u1ed7 0,95 USD tr\u00ean m\u1ed7i c\u1ed5 phi\u1ebfu trong qu\u00fd tr\u01b0\u1edbc. H\u1ecd c\u1ea7n th\u00e0nh c\u00f4ng th\u01b0\u01a1ng m\u1ea1i li\u00ean t\u1ee5c \u0111\u1ec3 \u0111\u1ea1t l\u1ee3i nhu\u1eadn<a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/08\/05\/3127793\/0\/en\/BridgeBio-Reports-Second-Quarter-2025-Financial-Results-and-Business-Updates.html\">(Globe Newswire)<\/a>.<\/li>\n<li><strong>C\u1ea1nh Tranh Gia T\u0103ng:<\/strong> C\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn h\u01a1n ng\u00e0y c\u00e0ng nh\u1eafm v\u00e0o c\u00e1c b\u1ec7nh di truy\u1ec1n hi\u1ebfm, c\u00f3 th\u1ec3 l\u00e0m gi\u1ea3m l\u1ee3i th\u1ebf \u0111i \u0111\u1ea7u c\u1ee7a BridgeBio.<\/li>\n<\/ul>\n<h2>\ud83d\udfe2 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c: T\u1ea1i Sao L\u1eadp Lu\u1eadn T\u0103ng Gi\u00e1 M\u1ea1nh M\u1ebd<\/h2>\n<ul>\n<li><strong>S\u1ee9c H\u00fat Th\u01b0\u01a1ng M\u1ea1i:<\/strong> Attruby t\u1ea1o ra 71,5 tri\u1ec7u USD doanh thu s\u1ea3n ph\u1ea9m r\u00f2ng trong qu\u00fd 2 n\u0103m 2025 v\u1edbi 3.751 \u0111\u01a1n thu\u1ed1c \u0111\u1ed9c nh\u1ea5t \u0111\u00e3 \u0111\u01b0\u1ee3c k\u00ea &#8211; g\u1ea7n nh\u01b0 t\u0103ng g\u1ea5p \u0111\u00f4i so v\u1edbi qu\u00fd tr\u01b0\u1edbc<a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/08\/05\/3127793\/0\/en\/BridgeBio-Reports-Second-Quarter-2025-Financial-Results-and-Business-Updates.html\">(Globe Newswire)<\/a>.<\/li>\n<li><strong>S\u1ee9c M\u1ea1nh T\u00e0i Ch\u00ednh:<\/strong> V\u1ecb th\u1ebf ti\u1ec1n m\u1eb7t 540,6 tri\u1ec7u USD c\u00f9ng v\u1edbi 300 tri\u1ec7u USD t\u1eeb vi\u1ec7c chuy\u1ec3n nh\u01b0\u1ee3ng b\u1ea3n quy\u1ec1n g\u1ea7n \u0111\u00e2y cung c\u1ea5p ngu\u1ed3n l\u1ef1c l\u1edbn cho ph\u00e1t tri\u1ec3n<a href=\"https:\/\/investor.bridgebio.com\/news\/news-details\/2025\/BridgeBio-Raises-300-Million-Through-Partial-Capped-Monetization-of-BEYONTTRA-European-Royalty\/default.aspx\">(BridgeBio Investor)<\/a>.<\/li>\n<li><strong>\u0110\u1ed9 S\u00e2u Pipeline:<\/strong> Nhi\u1ec1u ch\u01b0\u01a1ng tr\u00ecnh Giai \u0111o\u1ea1n 3 bao g\u1ed3m BBP-418 \u0111\u00e3 ho\u00e0n t\u1ea5t tuy\u1ec3n d\u1ee5ng tr\u01b0\u1edbc k\u1ebf ho\u1ea1ch, t\u1ea1o ra nhi\u1ec1u ch\u1ea5t x\u00fac t\u00e1c ti\u1ec1m n\u0103ng<a href=\"https:\/\/investor.bridgebio.com\/overview\/default.aspx\">(BridgeBio Overview)<\/a>.<\/li>\n<li><strong>H\u1ed7 Tr\u1ee3 T\u1eeb Nh\u00e0 Ph\u00e2n T\u00edch:<\/strong> 16 nh\u00e0 ph\u00e2n t\u00edch theo d\u00f5i BBIO v\u1edbi 7 khuy\u1ebfn ngh\u1ecb Mua M\u1ea1nh v\u00e0 9 khuy\u1ebfn ngh\u1ecb Mua &#8211; kh\u00f4ng c\u00f3 khuy\u1ebfn ngh\u1ecb Gi\u1eef ho\u1eb7c B\u00e1n n\u00e0o<a href=\"https:\/\/stockanalysis.com\/stocks\/bbio\/forecast\/\">(Stock Analysis)<\/a>.<\/li>\n<\/ul>\n<h2>\ud83c\udfaf K\u1ebf Ho\u1ea1ch H\u00e0nh \u0110\u1ed9ng Cho Nh\u00e0 Giao D\u1ecbch M\u1edbi<\/h2>\n<p><strong>Nh\u1eefng b\u01b0\u1edbc \u0111i th\u00f4ng minh h\u00f4m nay:<\/strong><\/p>\n<ol>\n<li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf:<\/strong> Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 3-5% danh m\u1ee5c \u0111\u1ea7u t\u01b0 cho BBIO ban \u0111\u1ea7u &#8211; c\u00f4ng ngh\u1ec7 sinh h\u1ecdc v\u1ed1n c\u00f3 r\u1ee7i ro cao<\/li>\n<li><strong>Trung b\u00ecnh gi\u00e1 mua:<\/strong> C\u00e2n nh\u1eafc mua theo t\u1eebng ph\u1ea7n thay v\u00ec m\u1ed9t l\u1ea7n \u0111\u1ec3 gi\u1ea3m thi\u1ec3u bi\u1ebfn \u0111\u1ed9ng<\/li>\n<li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o cho th\u00e1ng 11:<\/strong> \u0110\u00e1nh d\u1ea5u l\u1ecbch cho b\u00e1o c\u00e1o thu nh\u1eadp qu\u00fd 3 &#8211; \u0111\u00e2y c\u00f3 th\u1ec3 l\u00e0 \u0111i\u1ec3m v\u00e0o t\u1ed1t nh\u1ea5t n\u1ebfu c\u00f3 s\u1ef1 gi\u1ea3m gi\u00e1 sau b\u00e1o c\u00e1o<\/li>\n<li><strong>Gi\u00e1m s\u00e1t kh\u1ed1i l\u01b0\u1ee3ng:<\/strong> C\u00e1c ng\u00e0y c\u00f3 kh\u1ed1i l\u01b0\u1ee3ng cao th\u01b0\u1eddng b\u00e1o hi\u1ec7u c\u00e1c bi\u1ebfn \u0111\u1ed9ng l\u1edbn &#8211; d\u00f9ng ch\u00fang l\u00e0m t\u00edn hi\u1ec7u v\u00e0o l\u1ec7nh b\u1ed5 sung<\/li>\n<\/ol>\n<p><strong>Ch\u00e2m ng\u00f4n h\u00e0i h\u01b0\u1edbc t\u1eeb ng\u01b0\u1eddi c\u00f3 kinh nghi\u1ec7m:<\/strong> &#8220;Giao d\u1ecbch BBIO gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc xu\u1ea5t s\u1eafc &#8211; c\u1ef1c k\u1ef3 b\u1ed5 \u00edch nh\u01b0ng d\u1ec5 c\u00f3 nh\u1eefng bi\u1ebfn \u0111\u1ed9ng t\u00e2m tr\u1ea1ng m\u1ea1nh d\u1ef1a tr\u00ean k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m. \u0110\u1eebng c\u1ea7u h\u00f4n ngay bu\u1ed5i h\u1eb9n \u0111\u1ea7u!&#8221;<\/p>\n<h2>\u2705 H\u01b0\u1edbng D\u1eabn T\u1eebng B\u01b0\u1edbc: C\u00e1ch Mua C\u1ed5 Phi\u1ebfu BridgeBio Pharma, Inc. (BBIO)<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn N\u1ec1n T\u1ea3ng Giao D\u1ecbch<\/td>\n<td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng c\u00f3 truy c\u1eadp NASDAQ v\u00e0 ph\u00ed hoa h\u1ed3ng h\u1ee3p l\u00fd<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Ho\u00e0n Th\u00e0nh N\u1ea1p Ti\u1ec1n V\u00e0o T\u00e0i Kho\u1ea3n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i r\u1ee7i ro &#8211; ngay c\u1ea3 100 USD c\u0169ng c\u00f3 th\u1ec3 gi\u00fap b\u1ea1n b\u1eaft \u0111\u1ea7u<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>T\u00ecm ki\u1ebfm &#8220;BBIO&#8221;<\/td>\n<td>S\u1eed d\u1ee5ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ph\u1ea3i t\u00ean c\u00f4ng ty, \u0111\u1ec3 c\u00f3 k\u1ebft qu\u1ea3 ch\u00ednh x\u00e1c<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Ch\u1ecdn Lo\u1ea1i L\u1ec7nh<\/td>\n<td>D\u00f9ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o thay v\u00ec l\u1ec7nh th\u1ecb tr\u01b0\u1eddng<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Xem l\u1ea1i v\u00e0 X\u00e1c nh\u1eadn<\/td>\n<td>Ki\u1ec3m tra k\u1ef9 c\u00e1c chi ti\u1ebft l\u1ec7nh v\u00e0 ph\u00ed tr\u01b0\u1edbc khi ho\u00e0n t\u1ea5t<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option L\u00e0 L\u1ef1a Ch\u1ecdn H\u1ee3p L\u00fd Cho Giao D\u1ecbch BBIO<\/h2>\n<p>\u0110\u1ed1i v\u1edbi c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 mu\u1ed1n giao d\u1ecbch c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO), Pocket Option cung c\u1ea5p nhi\u1ec1u l\u1ee3i th\u1ebf n\u1ed5i b\u1eadt ph\u00f9 h\u1ee3p ho\u00e0n h\u1ea3o v\u1edbi \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc:<\/p>\n<ul>\n<li><strong>Ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u linh ho\u1ea1t:<\/strong> Ch\u1ec9 c\u1ea7n 5 USD \u0111\u1ec3 b\u1eaft \u0111\u1ea7u, b\u1ea1n c\u00f3 th\u1ec3 th\u1eed nghi\u1ec7m c\u00e1c chi\u1ebfn l\u01b0\u1ee3c v\u1edbi r\u1ee7i ro t\u1ed1i thi\u1ec3u tr\u01b0\u1edbc khi cam k\u1ebft s\u1ed1 ti\u1ec1n l\u1edbn h\u01a1n v\u00e0o l\u0129nh v\u1ef1c bi\u1ebfn \u0111\u1ed9ng n\u00e0y.<\/li>\n<li><strong>X\u00e1c minh t\u00e0i kho\u1ea3n nhanh ch\u00f3ng:<\/strong> Quy tr\u00ecnh KYC ch\u1ec9 m\u1ea5t 1 ph\u00fat gi\u00fap b\u1ea1n t\u1eadn d\u1ee5ng tin t\u1ee9c n\u00f3ng ho\u1eb7c bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u1ed9t ng\u1ed9t m\u00e0 kh\u00f4ng ph\u1ea3i ch\u1edd \u0111\u1ee3i nhi\u1ec1u ng\u00e0y \u0111\u1ec3 \u0111\u01b0\u1ee3c duy\u1ec7t t\u00e0i kho\u1ea3n.<\/li>\n<li><strong>Nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n:<\/strong> H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n \u0111\u1ea3m b\u1ea3o b\u1ea1n c\u00f3 th\u1ec3 nhanh ch\u00f3ng ti\u1ebfp c\u1eadn l\u1ee3i nhu\u1eadn khi BBIO c\u00f3 nh\u1eefng \u0111\u1ee3t t\u0103ng gi\u00e1 \u0111\u1eb7c tr\u01b0ng c\u1ee7a c\u00f4ng ngh\u1ec7 sinh h\u1ecdc.<\/li>\n<\/ul>\n<p>C\u1ea5u tr\u00fac n\u1ec1n t\u1ea3ng n\u00e0y \u0111\u1eb7c bi\u1ec7t c\u00f3 gi\u00e1 tr\u1ecb cho giao d\u1ecbch c\u00e1c c\u1ed5 phi\u1ebfu nh\u01b0 BBIO c\u00f3 th\u1ec3 bi\u1ebfn \u0111\u1ed9ng 10-20% ch\u1ec9 trong m\u1ed9t s\u1ef1 ki\u1ec7n tin t\u1ee9c, cho ph\u00e9p b\u1ea1n v\u00e0o v\u00e0 tho\u00e1t v\u1ecb th\u1ebf v\u1edbi s\u1ef1 linh ho\u1ea1t t\u1ed1i \u0111a.<\/p>\n<h2>\ud83e\uddec BridgeBio N\u0103m 2025: Ti\u00ean Phong Y H\u1ecdc Di Truy\u1ec1n<\/h2>\n<p>BridgeBio Pharma \u0111\u00e3 kh\u1eb3ng \u0111\u1ecbnh m\u00ecnh l\u00e0 m\u1ed9t c\u00f4ng ty d\u01b0\u1ee3c ph\u1ea9m giai \u0111o\u1ea1n th\u01b0\u01a1ng m\u1ea1i t\u1eadp trung ho\u00e0n to\u00e0n v\u00e0o ph\u00e1t tri\u1ec3n c\u00e1c lo\u1ea1i thu\u1ed1c chuy\u1ec3n \u0111\u1ed5i cho c\u00e1c b\u1ec7nh di truy\u1ec1n v\u00e0 m\u1ed9t s\u1ed1 lo\u1ea1i ung th\u01b0<a href=\"https:\/\/investor.bridgebio.com\/overview\/default.aspx\">(BridgeBio Overview)<\/a>. Th\u00e0nh l\u1eadp n\u0103m 2015, c\u00f4ng ty ho\u1ea1t \u0111\u1ed9ng to\u00e0n c\u1ea7u v\u1edbi s\u1ef1 hi\u1ec7n di\u1ec7n t\u1ea1i B\u1eafc M\u1ef9 v\u00e0 ch\u00e2u \u00c2u.<\/p>\n<p>M\u00f4 h\u00ecnh kinh doanh c\u1ee7a c\u00f4ng ty k\u1ebft h\u1ee3p ph\u00e1t hi\u1ec7n thu\u1ed1c n\u1ed9i b\u1ed9 v\u1edbi c\u00e1c \u0111\u1ed1i t\u00e1c chi\u1ebfn l\u01b0\u1ee3c, hi\u1ec7n \u0111ang ti\u1ebfp th\u1ecb b\u1ed1n lo\u1ea1i thu\u1ed1c \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t trong khi duy tr\u00ec m\u1ed9t pipeline m\u1ea1nh m\u1ebd bao g\u1ed3m c\u00e1c l\u0129nh v\u1ef1c tim th\u1eadn ch\u00ednh x\u00e1c, b\u1ec7nh di truy\u1ec1n Mendelian, ung th\u01b0 ch\u00ednh x\u00e1c v\u00e0 li\u1ec7u ph\u00e1p gen<a href=\"https:\/\/investor.bridgebio.com\/overview\/default.aspx\">(BridgeBio Overview)<\/a>.<\/p>\n<p><strong>S\u1ef1 ki\u1ec7n th\u00fa v\u1ecb n\u0103m 2025<\/strong>: Thu\u1ed1c Attruby c\u1ee7a BridgeBio \u0111\u00e3 \u0111\u1ea1t \u0111\u01b0\u1ee3c \u0111i\u1ec1u \u0111\u00e1ng ch\u00fa \u00fd &#8211; t\u1ea1o ra 3.751 \u0111\u01a1n thu\u1ed1c b\u1ec7nh nh\u00e2n \u0111\u1ed9c nh\u1ea5t ch\u1ec9 trong ch\u00edn th\u00e1ng k\u1ec3 t\u1eeb khi \u0111\u01b0\u1ee3c FDA ph\u00ea duy\u1ec7t, v\u1edbi t\u1ed1c \u0111\u1ed9 \u00e1p d\u1ee5ng g\u1ea7n nh\u01b0 t\u0103ng g\u1ea5p \u0111\u00f4i theo t\u1eebng qu\u00fd<a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/08\/05\/3127793\/0\/en\/BridgeBio-Reports-Second-Quarter-2025-Financial-Results-and-Business-Updates.html\">(Globe Newswire)<\/a>. T\u1ed1c \u0111\u1ed9 th\u01b0\u01a1ng m\u1ea1i n\u00e0y g\u1ea7n nh\u01b0 ch\u01b0a t\u1eebng c\u00f3 trong l\u0129nh v\u1ef1c b\u1ec7nh hi\u1ebfm v\u00e0 th\u1ec3 hi\u1ec7n c\u1ea3 nhu c\u1ea7u y t\u1ebf v\u00e0 s\u1ef1 xu\u1ea5t s\u1eafc trong th\u1ef1c thi.<\/p>\n"},"faq":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO)?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu BBIO th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch ch\u1ee9ng kho\u00e1n c\u00f3 truy c\u1eadp NASDAQ. H\u00e3y ch\u1ecdn n\u1ec1n t\u1ea3ng ph\u00f9 h\u1ee3p, n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n, t\u00ecm m\u00e3 BBIO, ch\u1ecdn lo\u1ea1i l\u1ec7nh v\u00e0 x\u00e1c nh\u1eadn giao d\u1ecbch."},{"question":"BridgeBio Pharma t\u1eadp trung v\u00e0o l\u0129nh v\u1ef1c n\u00e0o?","answer":"BridgeBio Pharma t\u1eadp trung ph\u00e1t tri\u1ec3n c\u00e1c lo\u1ea1i thu\u1ed1c \u0111\u1ed9t ph\u00e1 cho c\u00e1c b\u1ec7nh di truy\u1ec1n hi\u1ebfm g\u1eb7p v\u00e0 m\u1ed9t s\u1ed1 lo\u1ea1i ung th\u01b0, v\u1edbi m\u00f4 h\u00ecnh k\u1ebft h\u1ee3p ph\u00e1t hi\u1ec7n thu\u1ed1c n\u1ed9i b\u1ed9 v\u00e0 h\u1ee3p t\u00e1c chi\u1ebfn l\u01b0\u1ee3c."},{"question":"R\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o BBIO l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro ch\u00ednh bao g\u1ed3m bi\u1ebfn \u0111\u1ed9ng gi\u00e1 cao do tin t\u1ee9c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, ph\u1ee5 thu\u1ed9c v\u00e0o ph\u00ea duy\u1ec7t c\u1ee7a FDA v\u00e0 EMA, ti\u00eau hao ti\u1ec1n m\u1eb7t, v\u00e0 c\u1ea1nh tranh gia t\u0103ng t\u1eeb c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn."},{"question":"D\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu BBIO trong t\u01b0\u01a1ng lai nh\u01b0 th\u1ebf n\u00e0o?","answer":"D\u1ef1 b\u00e1o \u0111\u1ebfn cu\u1ed1i n\u0103m 2025 l\u00e0 52-62 USD v\u1edbi khuy\u1ebfn ngh\u1ecb mua m\u1ea1nh. C\u00e1c n\u0103m ti\u1ebfp theo c\u00f3 s\u1ef1 bi\u1ebfn \u0111\u1ed9ng, v\u1edbi ti\u1ec1m n\u0103ng t\u0103ng l\u00ean 55-70 USD v\u00e0o n\u0103m 2028 v\u00e0 dao \u0111\u1ed9ng 22-36 USD v\u00e0o n\u0103m 2030 do c\u00e1c y\u1ebfu t\u1ed1 d\u00e0i h\u1ea1n."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 giao d\u1ecbch BBIO?","answer":"Pocket Option c\u00f3 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, x\u00e1c minh t\u00e0i kho\u1ea3n nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n v\u00e0 ph\u00f9 h\u1ee3p v\u1edbi giao d\u1ecbch c\u00e1c c\u1ed5 phi\u1ebfu bi\u1ebfn \u0111\u1ed9ng cao nh\u01b0 BBIO, gi\u00fap b\u1ea1n linh ho\u1ea1t v\u00e0o v\u00e0 tho\u00e1t v\u1ecb th\u1ebf."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO)?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu BBIO th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch ch\u1ee9ng kho\u00e1n c\u00f3 truy c\u1eadp NASDAQ. H\u00e3y ch\u1ecdn n\u1ec1n t\u1ea3ng ph\u00f9 h\u1ee3p, n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n, t\u00ecm m\u00e3 BBIO, ch\u1ecdn lo\u1ea1i l\u1ec7nh v\u00e0 x\u00e1c nh\u1eadn giao d\u1ecbch."},{"question":"BridgeBio Pharma t\u1eadp trung v\u00e0o l\u0129nh v\u1ef1c n\u00e0o?","answer":"BridgeBio Pharma t\u1eadp trung ph\u00e1t tri\u1ec3n c\u00e1c lo\u1ea1i thu\u1ed1c \u0111\u1ed9t ph\u00e1 cho c\u00e1c b\u1ec7nh di truy\u1ec1n hi\u1ebfm g\u1eb7p v\u00e0 m\u1ed9t s\u1ed1 lo\u1ea1i ung th\u01b0, v\u1edbi m\u00f4 h\u00ecnh k\u1ebft h\u1ee3p ph\u00e1t hi\u1ec7n thu\u1ed1c n\u1ed9i b\u1ed9 v\u00e0 h\u1ee3p t\u00e1c chi\u1ebfn l\u01b0\u1ee3c."},{"question":"R\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o BBIO l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro ch\u00ednh bao g\u1ed3m bi\u1ebfn \u0111\u1ed9ng gi\u00e1 cao do tin t\u1ee9c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, ph\u1ee5 thu\u1ed9c v\u00e0o ph\u00ea duy\u1ec7t c\u1ee7a FDA v\u00e0 EMA, ti\u00eau hao ti\u1ec1n m\u1eb7t, v\u00e0 c\u1ea1nh tranh gia t\u0103ng t\u1eeb c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn."},{"question":"D\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu BBIO trong t\u01b0\u01a1ng lai nh\u01b0 th\u1ebf n\u00e0o?","answer":"D\u1ef1 b\u00e1o \u0111\u1ebfn cu\u1ed1i n\u0103m 2025 l\u00e0 52-62 USD v\u1edbi khuy\u1ebfn ngh\u1ecb mua m\u1ea1nh. C\u00e1c n\u0103m ti\u1ebfp theo c\u00f3 s\u1ef1 bi\u1ebfn \u0111\u1ed9ng, v\u1edbi ti\u1ec1m n\u0103ng t\u0103ng l\u00ean 55-70 USD v\u00e0o n\u0103m 2028 v\u00e0 dao \u0111\u1ed9ng 22-36 USD v\u00e0o n\u0103m 2030 do c\u00e1c y\u1ebfu t\u1ed1 d\u00e0i h\u1ea1n."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 giao d\u1ecbch BBIO?","answer":"Pocket Option c\u00f3 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, x\u00e1c minh t\u00e0i kho\u1ea3n nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n v\u00e0 ph\u00f9 h\u1ee3p v\u1edbi giao d\u1ecbch c\u00e1c c\u1ed5 phi\u1ebfu bi\u1ebfn \u0111\u1ed9ng cao nh\u01b0 BBIO, gi\u00fap b\u1ea1n linh ho\u1ea1t v\u00e0o v\u00e0 tho\u00e1t v\u1ecb th\u1ebf."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-20T14:18:06+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO)\",\"datePublished\":\"2025-08-20T14:18:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/\"},\"wordCount\":23,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"datePublished\":\"2025-08-20T14:18:06+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-20T14:18:06+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO)","datePublished":"2025-08-20T14:18:06+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/"},"wordCount":23,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","datePublished":"2025-08-20T14:18:06+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu BridgeBio Pharma, Inc. (BBIO)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":341227,"slug":"how-to-buy-bridgebio-pharma","post_title":"Como comprar a\u00e7\u00f5es da BridgeBio Pharma, Inc. (BBIO) - Investimento em a\u00e7\u00f5es da BridgeBio Pharma, Inc. (BBIO)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-bridgebio-pharma\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/341230","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=341230"}],"version-history":[{"count":1,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/341230\/revisions"}],"predecessor-version":[{"id":341232,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/341230\/revisions\/341232"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334117"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=341230"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=341230"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=341230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}